APA (7th ed.) Citation

O, Z., AM, A. D., B, Y., CY, L., SR, M., HG, D., . . . MS, D. (2024). Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activity. JCI insight, 9(3), . https://doi.org/10.1172/jci.insight.176359

Chicago Style (17th ed.) Citation

O, Zimmerman, et al. "Immunoglobulin Replacement Products Protect Against SARS-CoV-2 Infection in Vivo Despite Poor Neutralizing Activity." JCI Insight 9, no. 3 (2024). https://doi.org/10.1172/jci.insight.176359.

MLA (9th ed.) Citation

O, Zimmerman, et al. "Immunoglobulin Replacement Products Protect Against SARS-CoV-2 Infection in Vivo Despite Poor Neutralizing Activity." JCI Insight, vol. 9, no. 3, 2024, https://doi.org/10.1172/jci.insight.176359.